The Effects of Combined h[Gly2]Glucagon-Like Peptide-2 and Exendin-4 on Parameters Relevant to Short Bowel Syndrome
Year: 2021
Type: dissertation
Abstract: The intestinotrophic hormone, Glucagon-Like Peptide-2 mimetic h[Gly2]GLP2 is used to treat patients with Short Bowel Syndrome. GLP-1 mimetics including Exendin-4(Ex4) improve metabolism but are also intestinotrophic. Given this overlap, intestinal growth and permeability, body weight (BW), and gastric emptying (GE) were investigated in male and female C57/BL6mice following h[Gly2]GLP2 and Ex4 treatment, alone and in combination at “low”, “medium”, and “high” doses. Only the h[Gly2]GLP2 low dose/Ex4 high combination increased small intestinal (SI) weight compared to vehicle and both mono-agonists, via increases in SI length and villus height. This combination also abolished Ex4 induced reductions in BW and GE. However, h[Gly2]GLP2 induced reductions in intestinal permeability were abrogated by this combination.These findings suggest that adding GLP-1 mimetics to GLP-2-based therapy improves intestinal growth without detrimental effects on BW and GE, although antagonistic effect on intestinal permeability, as well as use in SBS models necessitate further studies
Source: TSpace (University of Toronto)
Author: Srikrishnaraj, Arjuna
Institution: University of Toronto
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7133040428
